Does HUMAN IMMUNOGLOBULIN G\HYALURONIDASE Cause Sinusitis? 453 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 453 reports of Sinusitis have been filed in association with HUMAN IMMUNOGLOBULIN G\HYALURONIDASE. This represents 15.5% of all adverse event reports for HUMAN IMMUNOGLOBULIN G\HYALURONIDASE.
453
Reports of Sinusitis with HUMAN IMMUNOGLOBULIN G\HYALURONIDASE
15.5%
of all HUMAN IMMUNOGLOBULIN G\HYALURONIDASE reports
6
Deaths
192
Hospitalizations
How Dangerous Is Sinusitis From HUMAN IMMUNOGLOBULIN G\HYALURONIDASE?
Of the 453 reports, 6 (1.3%) resulted in death, 192 (42.4%) required hospitalization, and 2 (0.4%) were considered life-threatening.
Is Sinusitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for HUMAN IMMUNOGLOBULIN G\HYALURONIDASE. However, 453 reports have been filed with the FAERS database.
What Other Side Effects Does HUMAN IMMUNOGLOBULIN G\HYALURONIDASE Cause?
Inappropriate schedule of product administration (610)
Covid-19 (524)
Pneumonia (474)
Fatigue (448)
Headache (395)
Product dose omission issue (378)
Malaise (323)
Pyrexia (316)
Infusion site erythema (312)
Infusion site pain (285)
What Other Drugs Cause Sinusitis?
ETANERCEPT (9,620)
ADALIMUMAB (9,283)
METHOTREXATE (6,115)
ABATACEPT (5,458)
TOFACITINIB (5,422)
TOCILIZUMAB (5,271)
CERTOLIZUMAB PEGOL (4,997)
RITUXIMAB (4,659)
GOLIMUMAB (4,471)
HUMAN IMMUNOGLOBULIN G (4,409)
Which HUMAN IMMUNOGLOBULIN G\HYALURONIDASE Alternatives Have Lower Sinusitis Risk?
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE vs HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE vs HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE, RECOMBINANT
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE vs HUMAN RABIES VIRUS IMMUNE GLOBULIN
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE vs HUMAN RHO IMMUNE GLOBULIN
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE vs HUMIRA